REG - Oxford Nanopore Tech - Update on legal action against MGI Australia

Oxford Nanopore TechnologiesAnnouncement

27/02/2026 15:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260227:nRSa7750Ua&default-theme=true

RNS Number : 7750U  Oxford Nanopore Technologies plc  27 February 2026

27 February 2026

 

Oxford Nanopore Technologies plc

("Oxford Nanopore" or the "Company") 

Update on legal action against MGI Australia Pty Ltd., in the Federal Court
of Australia

 

Oxford Nanopore Technologies plc (LSE: ONT), the company delivering a new
generation of nanopore based molecular sensing, today noted that in the
Australian patent proceedings against MGI Australia Pty Ltd. et al. ("MGI"),
MGI has conceded that its "Cyclone SEQ WT02" infringes four of Oxford
Nanopore's Australian patents.

 

Justice Jackman confirmed at a recent case management hearing that liability
for infringement is not in dispute. A trial has been set for 2027 at which
MGI's remaining defences will be adjudicated. Consideration of additional or
enhanced damages will take place after the trial.

 

Separately, in the UK, Oxford Nanopore has issued proceedings in the High
Court alleging trade secrets infringement, breach of confidence and breach of
contract against multiple MGI/ BGI entities.

 

In both instances, Oxford Nanopore initiated legal proceedings to protect the
intellectual property ("IP") that underpins its sensing platform, supported by
patents granted in Australia and in many other jurisdictions. The Company
continues to invest in innovation and is committed to safeguarding this IP as
a core driver of long-term value creation for customers and partners
worldwide.

 

-ENDS-

 

For further information, please contact:

Oxford Nanopore Technologies plc

Investors:   ir@nanoporetech.com (mailto:ir@nanoporetech.com)

Media:       media@nanoporetech.com (mailto:media@nanoporetech.com)

Teneo Australia (communications adviser to the Company)

Scott McFarlane:  +61 493 119 547

Australian media: ONT-AUS@teneo.com (mailto:ONT-AUS@teneo.com)

 

About Oxford Nanopore Technologies plc:

Oxford Nanopore Technologies' goal is to bring the widest benefits to society
through enabling the analysis of anything, by anyone, anywhere. The Group has
developed a new generation of nanopore-based sensing technology that is
currently used for real-time, high-performance, accessible, and scalable
analysis of DNA and RNA. The technology is used in more than 125 countries,
to understand the biology of humans, plants, animals, bacteria, viruses and
environments as well as to understand diseases such as cancer.  Oxford
Nanopore's technology also has the potential to provide broad, high impact,
rapid insights in a number of areas including healthcare, food and
agriculture.

For more information please visit: www.nanoporetech.com
(http://www.nanoporetech.com/)

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCZDLFLQLLXBBZ



            Copyright 2019 Regulatory News Service, all rights reserved